In this work, the preparation process of the compounded tea based on Cyclocarya paliurus, Moringa leaves and lotus leaves was optimized by adopting a mixture design and using the total triterpenes, flavonoids, and polysaccharides as evaluation indicators, together with the sensory evaluation. The results showed that the optimized ratio of Cyclocarya paliurus, Moringa leaves and lotus leaves is 1.5:0.3:0.2 (W:W:W).
In this work, we obtained the water extracts of Dendrobium officinale Kimura et Migo, Astragalus membranaceus (Fisch.) Bunge, the leaves of Morus alba L., Pueraria lobata (Willd.) Ohwi, Panax notoginseng (Burk) F. H. Chen. Respectively. Then, we made a compound with these water extracts of Dendrobium officinale Kimura et Migo (13.33 %), Astragalus membranaceus (Fisch.) Bunge (29.17 %), the leaves of Morus alba L. (12.5 %), Pueraria lobata (Willd.) Ohwi (20.83 %), Panax notoginseng (Burk) F. H. Chen (6.95 %), accessory materials (17.22 %). Subsequently, we tested its in vivo hypoglycenic activity, and the results showed that this compound can reduce the blood sugar of the model mouse without toxicity.
Objective: to prepare an active compound from the extracts of four traditional Chinese medicines that can reduce blood lipids. Methods: In this study, the active components were respectively extracted from four Chinese herbal medicines, namely, "Cymbopogon flexuosus", "Salvia miltiorrhiza", "Panax ginseng" and "Pueraria lobata", and then the active components were mixed in different proportions to prepare a compound. Subsequently, the in vivo lipid-lowering effects were investigated, and the results showed that the compound prepared in this study has the efficacy of lowering blood lipids. Conclusion: The "compound" prepared in this study can be developed as a functional food or beverage with auxiliary lipid-lowering efficacy.
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.